|
mendelian randomization |
35 |
|
epidemiology |
22 |
|
hypertension |
21 |
|
cohort studies |
19 |
|
cardiovascular diseases |
18 |
|
type 2 diabetes |
16 |
|
chinese |
14 |
|
mendelian randomization analysis |
14 |
|
public health |
14 |
|
secondary prevention |
13 |
|
vitamin d |
13 |
|
ischemic stroke |
12 |
|
myocardial infarction |
12 |
|
recurrence |
12 |
|
diabetes |
11 |
|
ischemic heart disease |
11 |
|
paediatrics |
11 |
|
statistics & research methods |
11 |
|
stroke |
11 |
|
testosterone |
11 |
|
uk biobank |
11 |
|
exome chip |
10 |
|
blood pressure |
9 |
|
cholesterol |
9 |
|
estrogen |
9 |
|
menarche |
9 |
|
metabolomics |
9 |
|
odds ratio |
9 |
|
sleep duration |
9 |
|
cardiovascular disease |
8 |
|
cognition |
8 |
|
coronary heart disease |
8 |
|
covid-19 |
8 |
|
diabetes mellitus |
8 |
|
hand strength |
8 |
|
instrumental variable analysis |
8 |
|
length/height |
8 |
|
weight |
8 |
|
alzheimer’s disease |
7 |
|
bronchopulmonary dysplasia |
7 |
|
cancer |
7 |
|
drug repositioning |
7 |
|
genetic susceptibility |
7 |
|
genetics |
7 |
|
hba1c |
7 |
|
infant |
7 |
|
lean mass |
7 |
|
lung cancer |
7 |
|
lung function |
7 |
|
metabolic re-programming |
7 |
|
premature |
7 |
|
supplemental oxygen |
7 |
|
trimetazidine |
7 |
|
adolescents |
6 |
|
birth weight |
6 |
|
body mass index |
6 |
|
cardiovascular risk factors |
6 |
|
china |
6 |
|
cognitive function |
6 |
|
drug-target mendelian randomization |
6 |
|
fats |
6 |
|
genetic risk |
6 |
|
genome-wide association studies |
6 |
|
glycated hemoglobin |
6 |
|
grip strength |
6 |
|
hemoglobin |
6 |
|
hmgcr inhibitors |
6 |
|
inflammation |
6 |
|
lipids |
6 |
|
liver function |
6 |
|
mendelian randomisation |
6 |
|
metabolic syndrome |
6 |
|
pcsk9 inhibitors |
6 |
|
safety |
6 |
|
systematic review |
6 |
|
twin status |
6 |
|
type 2 diabetes mellitus |
6 |
|
adolescent |
5 |
|
adolescent obesity |
5 |
|
aldehyde dehydrogenase 2 |
5 |
|
asthma |
5 |
|
bmi |
5 |
|
breast feeding |
5 |
|
case-control study |
5 |
|
cognition - physiology |
5 |
|
coronary artery disease |
5 |
|
dementia |
5 |
|
diet |
5 |
|
estrogens - physiology |
5 |
|
fasting plasma glucose |
5 |
|
gut microbiome |
5 |
|
menarcheal age |
5 |
|
menopause |
5 |
|
physical activity |
5 |
|
postmenopause - blood - psychology |
5 |
|
puberty |
5 |
|
reproductive history |
5 |
|
risk factors |
5 |
|
women |
5 |
|
active transport |
4 |
|
adiposity |
4 |
|
adolescence |
4 |
|
adult |
4 |
|
alcohol |
4 |
|
alcohol drinking - genetics |
4 |
|
aldehyde dehydrogenase - genetics - metabolism |
4 |
|
ampk |
4 |
|
androgen |
4 |
|
asian continental ancestry group - genetics |
4 |
|
birth cohort |
4 |
|
cardiovascular |
4 |
|
cardiovascular disease risk factors |
4 |
|
causal effect |
4 |
|
children |
4 |
|
chinese men |
4 |
|
depressive symptoms |
4 |
|
electrocardiogram |
4 |
|
fat |
4 |
|
g6pd deficiency |
4 |
|
gene |
4 |
|
glucagon-like peptide-1 agonist |
4 |
|
hematocrit |
4 |
|
instrumental variable estimate |
4 |
|
isotemporal substitution |
4 |
|
mediation |
4 |
|
metformin |
4 |
|
metformin targets |
4 |
|
multiple births |
4 |
|
polymorphism, single nucleotide |
4 |
|
prospective study |
4 |
|
sedentary behaviour |
4 |
|
sleep |
4 |
|
southern chinese |
4 |
|
statins |
4 |
|
sugar-sweetened beverages |
4 |
|
treatment |
4 |
|
abdominal obesity |
3 |
|
ace2 |
3 |
|
aging |
3 |
|
artificial sweetener |
3 |
|
atherosclerotic cardiovascular disease |
3 |
|
birthweight |
3 |
|
body composition |
3 |
|
breast cancer screening |
3 |
|
cancers |
3 |
|
cardiometabolic risk markers |
3 |
|
cardiovascular risk factor |
3 |
|
causal inference |
3 |
|
coffee |
3 |
|
competing risk |
3 |
|
computer use |
3 |
|
disease aetiology |
3 |
|
ferritin |
3 |
|
fgf23 |
3 |
|
genetic epidemiology |
3 |
|
gestational diabetes mellitus |
3 |
|
gestational duration |
3 |
|
glucose |
3 |
|
glycaemic traits |
3 |
|
glycemia |
3 |
|
glycemic traits |
3 |
|
growth |
3 |
|
growth differentiation factor 15 |
3 |
|
healthy lifestyle |
3 |
|
hepcidin |
3 |
|
insulin |
3 |
|
intrinsic capacity |
3 |
|
iron |
3 |
|
kidney disease |
3 |
|
korean women |
3 |
|
lifestyle |
3 |
|
linearity |
3 |
|
liver cirrhosis |
3 |
|
liver iron |
3 |
|
liver steatosis |
3 |
|
longevity |
3 |
|
maternal hyperglycaemia |
3 |
|
mendelian randomization studies |
3 |
|
milk |
3 |
|
muscle |
3 |
|
muscle strength |
3 |
|
older adults |
3 |
|
polygenic risk scores |
3 |
|
prospective studies |
3 |
|
psychometric properties |
3 |
|
reporting guideline |
3 |
|
reporting quality |
3 |
|
screen‐based sedentary activities |
3 |
|
sedentary behavior |
3 |
|
selection bias |
3 |
|
sex hormones |
3 |
|
shared etiology |
3 |
|
south-asian ancestry |
3 |
|
sugar |
3 |
|
tv viewing |
3 |
|
venous thromboembolism |
3 |
|
adiponectin |
2 |
|
amyloid |
2 |
|
arachidonic acid |
2 |
|
atrial fibrillation |
2 |
|
bi-directional |
2 |
|
brain expression |
2 |
|
cardiometabolic diseases |
2 |
|
chronic obstructive pulmonary disease |
2 |
|
coagulation |
2 |
|
cohort study |
2 |
|
drinking of alcoholic beverages - china - hong kong. |
2 |
|
drinking of alcoholic beverages - health aspects. |
2 |
|
electronic healthcare records |
2 |
|
general population |
2 |
|
hba1c hemoglobin |
2 |
|
heart failure |
2 |
|
lipid |
2 |
|
mediation analysis |
2 |
|
mitochondrial function |
2 |
|
mortality |
2 |
|
non-diabetic individuals |
2 |
|
obesity |
2 |
|
observational analysis |
2 |
|
prostate cancer |
2 |
|
sglt2 inhibition |
2 |
|
smoking |
2 |
|
sodium |
2 |
|
soy product intake |
2 |
|
tau |
2 |
|
vascular endothelial growth factor |
2 |
|
25-hydroxyvitamin d |
1 |
|
adverse care experiences |
1 |
|
all-cause mortality |
1 |
|
biobank studies |
1 |
|
cause-specific mortality |
1 |
|
childhood socio-economic disadvantages |
1 |
|
cohort |
1 |
|
diabetes mellitus, type 2 |
1 |
|
east asians |
1 |
|
eczema |
1 |
|
forced expiratory volume |
1 |
|
late-life depressive symptoms |
1 |
|
low birth weight |
1 |
|
lung |
1 |
|
macrosomia |
1 |
|
menopausal hormone therapy |
1 |
|
moderation |
1 |
|
prenatal depressive symptoms |
1 |
|
snoring |
1 |
|
socioeconomic position |
1 |
|
time-varying mortality estimates |
1 |
|
vital capacity |
1 |
|
vitamin d supplementation |
1 |
